BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28378549)

  • 1. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.
    Sung TY; Choi YM; Kim WG; Lee YM; Kim TY; Shong YK; Kim WB; Song DE
    J Korean Med Sci; 2017 May; 32(5):764-771. PubMed ID: 28378549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological study of adrenocortical carcinoma with special reference to the Weiss system and TNM staging and the role of immunohistochemistry to differentiate it from renal cell carcinoma.
    Mondal SK; Dasgupta S; Jain P; Mandal PK; Sinha SK
    J Cancer Res Ther; 2013; 9(3):436-41. PubMed ID: 24125979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
    Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
    Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease.
    Asare EA; Wang TS; Winchester DP; Mallin K; Kebebew E; Sturgeon C
    Surgery; 2014 Dec; 156(6):1378-85; discussion 1385-6. PubMed ID: 25456914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
    Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.
    Yamazaki Y; Nakamura Y; Shibahara Y; Konosu-Fukaya S; Sato N; Kubota-Nakayama F; Oki Y; Baba S; Midorikawa S; Morimoto R; Satoh F; Sasano H
    Hum Pathol; 2016 Jul; 53():41-50. PubMed ID: 26980031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.
    Morimoto R; Satoh F; Murakami O; Suzuki T; Abe T; Tanemoto M; Abe M; Uruno A; Ishidoya S; Arai Y; Takahashi K; Sasano H; Ito S
    Endocr J; 2008 Mar; 55(1):49-55. PubMed ID: 18187873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
    Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
    Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature.
    Wanis KN; Kanthan R
    World J Surg Oncol; 2015 Mar; 13():117. PubMed ID: 25889798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma: Usefulness of the Ki-67 Index.
    Choi YM; Kwon H; Jeon MJ; Sung TY; Hong SJ; Kim TY; Kim WB; Shong YK; Lee JL; Song DE; Kim WG
    Medicine (Baltimore); 2016 May; 95(21):e3736. PubMed ID: 27227935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
    Beuschlein F; Weigel J; Saeger W; Kroiss M; Wild V; Daffara F; Libé R; Ardito A; Al Ghuzlan A; Quinkler M; Oßwald A; Ronchi CL; de Krijger R; Feelders RA; Waldmann J; Willenberg HS; Deutschbein T; Stell A; Reincke M; Papotti M; Baudin E; Tissier F; Haak HR; Loli P; Terzolo M; Allolio B; Müller HH; Fassnacht M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):841-9. PubMed ID: 25559399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017.
    Gupta N; Rivera M; Novotny P; Rodriguez V; Bancos I; Lteif A
    Horm Res Paediatr; 2018; 90(1):8-18. PubMed ID: 29804118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocortical carcinoma surgery-surgical extent and approach.
    Vanbrugghe C; Lowery AJ; Golffier C; Taieb D; Sebag F
    Langenbecks Arch Surg; 2016 Nov; 401(7):991-997. PubMed ID: 27412357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adrenocortical cancer: morphological variants, immunohistochemical characteristics].
    Tkachuk AV; Tertychnyi AS; Beltsevich DG; Roslyakova AA; Belousov PV; Selivanova LS
    Arkh Patol; 2021; 83(3):10-18. PubMed ID: 33822549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.
    Ayala-Ramirez M; Jasim S; Feng L; Ejaz S; Deniz F; Busaidy N; Waguespack SG; Naing A; Sircar K; Wood CG; Pagliaro L; Jimenez C; Vassilopoulou-Sellin R; Habra MA
    Eur J Endocrinol; 2013 Dec; 169(6):891-899. PubMed ID: 24086089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myxoid variant of adrenocortical carcinoma: report of a unique case.
    Karim RZ; Wills EJ; McCarthy SW; Scolyer RA
    Pathol Int; 2006 Feb; 56(2):89-94. PubMed ID: 16445821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience.
    Tsai WH; Dai SH; Lee CC; Chien MN; Zeng YH
    Curr Oncol; 2023 Apr; 30(4):4117-4125. PubMed ID: 37185426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resection of adrenocortical carcinoma liver metastasis: is it justified?
    Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
    Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
    Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E;
    Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
    Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
    BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.